These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 20735469)

  • 21. Mitochondrial dysfunctions in Parkinson's disease.
    Gautier CA; Corti O; Brice A
    Rev Neurol (Paris); 2014 May; 170(5):339-43. PubMed ID: 24119854
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drosophila as a model to study mitochondrial dysfunction in Parkinson's disease.
    Guo M
    Cold Spring Harb Perspect Med; 2012 Nov; 2(11):. PubMed ID: 23024178
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mitochondrial dynamics and Parkinson's disease: focus on parkin.
    Lim KL; Ng XH; Grace LG; Yao TP
    Antioxid Redox Signal; 2012 May; 16(9):935-49. PubMed ID: 21668405
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mitochondrial metabolism modulation: a new therapeutic approach for Parkinson's disease.
    Arduíno DM; Esteves AR; Oliveira CR; Cardoso SM
    CNS Neurol Disord Drug Targets; 2010 Mar; 9(1):105-19. PubMed ID: 20201821
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DJ-1 regulation of mitochondrial function and autophagy through oxidative stress.
    McCoy MK; Cookson MR
    Autophagy; 2011 May; 7(5):531-2. PubMed ID: 21317550
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mitochondrial dysfunction in Parkinson's disease.
    Bose A; Beal MF
    J Neurochem; 2016 Oct; 139 Suppl 1():216-231. PubMed ID: 27546335
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mitochondrial acetylation and genetic models of Parkinson's disease.
    Auburger G; Gispert S; Jendrach M
    Prog Mol Biol Transl Sci; 2014; 127():155-82. PubMed ID: 25149217
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Autophagic pathways in Parkinson disease and related disorders.
    Xilouri M; Stefanis L
    Expert Rev Mol Med; 2011 Mar; 13():e8. PubMed ID: 21418705
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mitochondria in the aetiology and pathogenesis of Parkinson's disease.
    Schapira AH
    Lancet Neurol; 2008 Jan; 7(1):97-109. PubMed ID: 18093566
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mitochondrial-Associated Membranes in Parkinson's Disease.
    Hattori N; Arano T; Hatano T; Mori A; Imai Y
    Adv Exp Med Biol; 2017; 997():157-169. PubMed ID: 28815529
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeting mitochondria for neuroprotection in Parkinson's disease.
    Schapira AH
    Antioxid Redox Signal; 2012 May; 16(9):965-73. PubMed ID: 22229791
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mitochondrial and autophagic alterations in skin fibroblasts from Parkinson disease patients with Parkin mutations.
    González-Casacuberta I; Juárez-Flores DL; Ezquerra M; Fucho R; Catalán-García M; Guitart-Mampel M; Tobías E; García-Ruiz C; Fernández-Checa JC; Tolosa E; Martí MJ; Grau JM; Fernández-Santiago R; Cardellach F; Morén C; Garrabou G
    Aging (Albany NY); 2019 Jun; 11(11):3750-3767. PubMed ID: 31180333
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Trumping neurodegeneration: Targeting common pathways regulated by autosomal recessive Parkinson's disease genes.
    Scott L; Dawson VL; Dawson TM
    Exp Neurol; 2017 Dec; 298(Pt B):191-201. PubMed ID: 28445716
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tickled PINK1: mitochondrial homeostasis and autophagy in recessive Parkinsonism.
    Chu CT
    Biochim Biophys Acta; 2010 Jan; 1802(1):20-8. PubMed ID: 19595762
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The genetic architecture of mitochondrial dysfunction in Parkinson's disease.
    Larsen SB; Hanss Z; Krüger R
    Cell Tissue Res; 2018 Jul; 373(1):21-37. PubMed ID: 29372317
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Defective quality control mechanisms and accumulation of damaged mitochondria link Gaucher and Parkinson diseases.
    Osellame LD; Duchen MR
    Autophagy; 2013 Oct; 9(10):1633-5. PubMed ID: 23989665
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mitochondrial function and autophagy: integrating proteotoxic, redox, and metabolic stress in Parkinson's disease.
    Zhang J; Culp ML; Craver JG; Darley-Usmar V
    J Neurochem; 2018 Mar; 144(6):691-709. PubMed ID: 29341130
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Unravelling mitochondrial pathways to Parkinson's disease.
    Celardo I; Martins LM; Gandhi S
    Br J Pharmacol; 2014 Apr; 171(8):1943-57. PubMed ID: 24117181
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The interplay of neuronal mitochondrial dynamics and bioenergetics: implications for Parkinson's disease.
    Van Laar VS; Berman SB
    Neurobiol Dis; 2013 Mar; 51():43-55. PubMed ID: 22668779
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Emerging (and converging) pathways in Parkinson's disease: keeping mitochondrial wellness.
    Cieri D; Brini M; Calì T
    Biochem Biophys Res Commun; 2017 Feb; 483(4):1020-1030. PubMed ID: 27581196
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.